Global pharmaceutical companies do not reduce payments for the promotion of drugs in Russia
Many global pharmaceutical companies, having abandoned direct advertising of their drugs in Russia after the outbreak of hostilities in Ukraine,...
Many global pharmaceutical companies, having abandoned direct advertising of their drugs in Russia after the outbreak of hostilities in Ukraine,...
The U.S. may face a shortage of a number of medical supplies after a Pfizer pharmaceutical plant was destroyed by...
The Ministry of Industry and Trade of the Russian Federation announced that there are no risks of a shortage of...
From September this year, a number of private medical organizations, including RZD-Medicine, Medsi and Innovative Technologies, will be able to...
+ A - To test it will be entrusted to kids and representatives of the older generation Requirements for the...
In the context of a general decline in the purchase of medicines by the public sector, some players are increasing...
The Finnish Orion Pharma, which is reducing its business in the Russian Federation, has sold part of its assets. Valenta...
The issuance of subsidized medicines in the Primorsky Territory has been temporarily suspended due to the hacking of the information...
New rules for the introduction of veterinary medicines into circulation from September 1 could reduce the number of available imported...
Prices for imported pharmaceutical substances are rising again after falling in 2022. According to the results of January-May, part of...
Parents of children with epilepsy have created a petition in which they ask the state to provide the country with...
Retail sales of drugs for cardiovascular diseases in the first five months of 2023 in monetary terms increased by 16%...
An expensive product is a relative concept and strongly depends on the financial capabilities, social status and lifestyle of the...
Federal medical centers have begun to purchase individual drugs by trade names more often, which may require a review of...
A research center and production of biotechnological products will appear on the territory of the Technopolis Moscow SEZ. This follows...